Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome

BACKGROUND: Current guidelines recommend the use of potent antiplatelet agents in patients undergoing percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS). However, data about optimal platelet inhibition in severe renal insufficiency patients are scarce. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunxian, Tu, Shaowen, Chen, Zhixin, Xia, Jue, Chen, Baofeng, Chen, Jinfeng, Liang, Jiarong, Liu, Xiangyang, Tang, Liangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357815/
https://www.ncbi.nlm.nih.gov/pubmed/35966043
http://dx.doi.org/10.1155/2022/6476777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357815/
https://www.ncbi.nlm.nih.gov/pubmed/35966043
http://dx.doi.org/10.1155/2022/6476777

Ejemplares similares